Cidara Therapeutics Inc. (CDTX)

18.93

-2.61 (-12.12%)

At close: Apr 01, 2025, 3:59 PM

18.92

-0.05%

After-hours: Apr 01, 2025, 04:40 PM EDT

Cidara Therapeutics Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-169.83M	-22.93M	-29.8M	-42.47M	-72.11M
Depreciation & Amortization	233K	118K	1.23M	-1.23M	229K
Stock-Based Compensation	3.91M	3.06M	3.53M	4.01M	4.09M
Other Working Capital	-33.3M	3.7M	-584K	8.62M	24.52M
Other Non-Cash Items	3.09M	1.24M	1K	15K	21K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-13.93M	-3.92M	-3.43M	14.44M	13.36M
Operating Cash Flow	-176.53M	-22.43M	-28.47M	-25.23M	-54.41M
Capital Expenditures	-129K	-505K	-118K	-41K	-186K
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-129K	-505K	-118K	-41K	-186K
Debt Repayment	-276K	n/a	-2.59M	-4.44M	-2.96M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	7K	21K	-720K	6K	14K
Financial Cash Flow	337.06M	25.98M	-951K	44.6M	37.28M
Net Cash Flow	160.4M	3.05M	-29.54M	19.32M	-17.32M
Free Cash Flow	-176.66M	-22.94M	-28.59M	-25.27M	-54.6M